Celcuity, Inc. (CELC)
90.05
+1.81
(+2.05%)
USD |
NASDAQ |
Jun 11, 15:02
Celcuity EPS Diluted (Quarterly) : -0.9702 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.9702 |
| December 31, 2025 | -0.9702 |
| September 30, 2025 | -0.9204 |
| June 30, 2025 | -1.037 |
| March 31, 2025 | -0.8593 |
| December 31, 2024 | -0.8549 |
| September 30, 2024 | -0.6962 |
| June 30, 2024 | -0.617 |
| March 31, 2024 | -0.643 |
| December 31, 2023 | -0.6522 |
| September 30, 2023 | -0.8321 |
| June 30, 2023 | -0.6644 |
| March 31, 2023 | -0.5506 |
| December 31, 2022 | -0.6864 |
| September 30, 2022 | -0.7292 |
| June 30, 2022 | -0.6671 |
| March 31, 2022 | -0.5319 |
| December 31, 2021 | -0.4529 |
| September 30, 2021 | -0.4051 |
| June 30, 2021 | -1.113 |
| Date | Value |
|---|---|
| March 31, 2021 | -0.2521 |
| December 31, 2020 | -0.2482 |
| September 30, 2020 | -0.2408 |
| June 30, 2020 | -0.2146 |
| March 31, 2020 | -0.2191 |
| December 31, 2019 | -0.1765 |
| September 30, 2019 | -0.1938 |
| June 30, 2019 | -0.1684 |
| March 31, 2019 | -0.181 |
| December 31, 2018 | -0.1796 |
| September 30, 2018 | -0.1847 |
| June 30, 2018 | -0.18 |
| March 31, 2018 | -0.1949 |
| December 31, 2017 | -0.17 |
| September 30, 2017 | -0.26 |
| June 30, 2017 | -0.28 |
| March 31, 2017 | -0.0038 |
| June 30, 2016 | -0.0843 |
| March 31, 2016 | -0.003 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -2.291 |
| Tango Therapeutics, Inc. | -0.317 |
| Kymera Therapeutics, Inc. | -0.7098 |
| Cogent Biosciences, Inc. | -0.60 |
| Erasca, Inc. | -0.6028 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -52.84M |
| Total Expenses (Quarterly) | 52.84M |
| Enterprise Value | 4.203B |
| Earnings Yield | -4.33% |
| Normalized Earnings Yield | -4.328 |